Responsive image

Common name


3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-benzimidazol-2-one

IUPAC name


3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-benzimidazol-2-one

SMILES


N1CCC(=CC1)n2c(=O)[nH]c3c2cccc3

Common name


3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-benzimidazol-2-one

IUPAC name


3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-benzimidazol-2-one

SMILES


N1CCC(=CC1)n2c(=O)[nH]c3c2cccc3

INCHI


InChI=1S/C12H13N3O/c16-12-14-10-3-1-2-4-11(10)15(12)9-5-7-13-8-6-9/h1-5,13H,6-8H2,(H,14,16)

FORMULA


C12H13N3O

Responsive image

Common name


3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-benzimidazol-2-one

IUPAC name


3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-benzimidazol-2-one





Molecular weight


215.251

clogP


-1.598

clogS


-2.539

Frequency


0.0003





HBond Acceptor


1

HBond Donor


2

Total Polar
Surface Area


41.13

Number of Rings


3

Rotatable Bond


1

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00325 Droperidol Responsive image Antipsychotic Agents; Adjuvants, Anesthesia; Adrenergic alpha-1 Receptor Antagonists; Antiemetics; Dopamine Antagonists; Nervous System; Psycholeptics; Butyrophenone Derivatives; Dopamine D2 Receptor Antagonists; Droperidol is ssed to produce tranquilization and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures.
1 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
2phb_ligand_2_9.mol2 2phb 0.392857 -7.54 C1=CN(C[C@@H]1OC)C(=O)Nc1ccc(cc1)Cl 17
4ocz_ligand.mol2 4ocz 0.381944 -9.61 FC(F)(F)c1ccc(cc1)NC(=O)NC1CCN(CC1)C(=O)C(C)C 26
4uwf_ligand_1_0.mol2 4uwf 0.369863 -7.02 c1c(cc(cc1F)F)N1c2[nH]ccc(=O)n2CCC1 19
2zmm_ligand_2_3.mol2 2zmm 0.368421 -7.05 C(=O)(NC)N(c1ccccc1)C1CCCCC1 17
4kpz_ligand.mol2 4kpz 0.364865 -7.87 c1cc(cc(c1)N(=O)=O)N1CCC(=O)NC1=O 18
100 , 11